Scaling up Health Services for Type 1 Diabetes in India, 2023
This report, “Scaling up Health Services for Type 1 Diabetes in India: Towards a strategy to transition to sustainability of programmes supported by CDIC in India ”, was developed under the guidance of Professor Rifat Atun, Professor of Global Health Systems at Harvard University and Director of the Health Systems Innovation Lab. The study was supported by Novo Nordisk financially supported this work through a research grant. The funders had no role in study design, analysis, decision to publish, or report preparation.
Improving Registries for Better Healthcare Services and Outcomes for Pediatric Type 1 Diabetes, 2022
This consensus paper outlines a renewed global surgery strategy to expand surgical healthcare in LMICs, given recent trends, research and empiricism in surgical healthcare and global health systems.
Edition 40 – The Evolution of WHIMS – What Healthcare Organizations Can Learn from Its Genesis, Development, and Future Potential
The Evolution of WHIMS – What Healthcare Organizations can learn from its genesis, development, and future potential By Dr Nadeem Ahmed, Gabriel Oke Share on facebook Facebook Share on twitter Twitter Share on linkedin LinkedIn Citation Ahmed N and Oke G. The evolution of WHIMS – What healthcare organizations can learn from its genesis, development, […]
Towards a Strategy for Improving Surgical Healthcare Worldwide, 2022
This consensus paper outlines a renewed global surgery strategy to expand surgical healthcare in LMICs, given recent trends, research and empiricism in surgical healthcare and global health systems.
Edition 40 – The Impact of Remote Recruitment and Intervention on Adolescents At-Risk for Cybervictimization
The Impact of Remote Recruitment and Intervention on Adolescents At-Risk for Cybervictimization By Chiaka Ibe, Megan Ranney, MD, MPH, FACEP; John Pateña, MPH, MA; Tyler Wray, PhD, Brown University Share on facebook Facebook Share on twitter Twitter Share on linkedin LinkedIn Citation Ibe C, Ranney M, Pateña J, Wray T. The impact of remote recruitment […]
Strategic Public-Private Partnerships to Transform Cardiovascular Health, 2022
The study, Strategic Public-Private Partnerships to Transform Cardiovascular Health, was developed under the guidance of Professor Rifat Atun, Professor of Global Health Systems at Harvard University and Director of the Health Systems Innovation Lab and implemented by the Health Systems Innovation Lab at Harvard University.
State of Cardiovascular Disease in G20+ Countries
This study was developed under the guidance of Professor Rifat Atun, Professor of Global Health Systems at the Harvard Chan School, Harvard University and Director of the Health Systems Innovation Lab, and Francesca Colombo, Head of the Health Division at the Organization for Economic Cooperation and Development (OECD) and implemented by a team of researchers and contributors from the Health Systems Innovation Lab (HSIL) at Harvard University and the OECD.
Appendix: Cardiovascular Disease in G20+ Countries
This is the appendix for the report, developed under the guidance of Professor Rifat Atun, Professor of Global Health Systems at the Harvard Chan School, Harvard University and Director of the Health Systems Innovation Lab, and Francesca Colombo, Head of the Health Division at the Organization for Economic Cooperation and Development (OECD) and implemented by a team of researchers and contributors from the Health Systems Innovation Lab (HSIL) at Harvard University and the OECD.
Edition 40 – Are We Ready for Telerehabilitation to Become Mainstream? Opinion About Upper Extremity Orthopedic Conditions
Are We Ready for Telerehabilitation to Become Mainstream? Opinion About Upper Extremity Orthopedic Conditions By Thierry Lienou, OTD, OTR/L, CAPS, ATP Facebook Twitter LinkedIn Citation Lienou T. Are we reaady for telerehabilitation to become mainstream? Opinion about upper extremity orthopediuc conditions. HPHR. 2021;40. DOI:10.54111/0001/NN3 Are we ready for telerehabilitation to become mainstream? Opinion about […]
Edition 40 – AI to Transform the Drug Approval Process and De-Risk Drug Development
AI to Transform the Drug Approval Process and De-Risk Drug Development By Cherubin Manokaran Facebook Twitter LinkedIn Citation Manokaran C. AI to transform the drug approval process and de-risk drug development. HPHR. 2021;40. 10.54111/0001/NN4 AI to Transform the Drug Approval Process and De-risk Drug Development Abstract The public tends to view high drug prices through […]